Literature DB >> 18245135

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

A Berglund, B Cedermark, B Glimelius.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18245135     DOI： 10.1093/annonc/mdm582

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

1.  Association Between Time (Initiation and Length) and Oncological Outcomes for the Patients with Colon Cancer Treated with Adjuvant Chemotherapy.

Authors:  In Seob Jeong; Jong Han Yoo; Sang Hyuk Seo; Min Sung An; Kwang Hee Kim; Ki Beom Bae; Chang Soo Choi; Jin Won Hwang; Ji Hyun Kim; Mi Seon Kang; Min Kyung Oh; Kwan Hee Hong
Journal:  Indian J Surg       Date:  2015-04-23       Impact factor: 0.656

2.  Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

Authors:  J M Vieitez; R García-Carbonero; J Aparicio; J Feliu; E González-Flores; E Grande; T Pérez-Hoyos; A Salud; E Torres; M Valero; M Valladares-Ayerbes; E Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

Review 3.  Adjuvant therapy for early colon cancer: current status.

Authors:  Alexander Stein; Sonja Hiemer; Hans-Joachim Schmoll
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

4.  Laparoscopy mitigates adverse oncological effects of delayed adjuvant chemotherapy for colon cancer.

Authors:  Gerald A Gantt; Jean Ashburn; Ravi P Kiran; Alok A Khorana; Matthew F Kalady
Journal:  Surg Endosc       Date:  2015-02       Impact factor: 4.584

5.  Survival following laparoscopic and open colorectal surgery.

Authors:  Andrew R Day; Ralph V P Smith; Iain C Jourdan; Tim A Rockall
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

6.  Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological study.

Authors:  Jean Capsec; Carole Lefebvre; Fabienne Chupé; Patrick Heitzmann; Céline Raveneau; Véronique Dardaine-Giraud; Carine Sauger; Jean-Paul Lagasse; Kevin Kraft; Claude Linassier; Etienne Dorval
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 7.  Sampling circulating tumor cells for clinical benefits: how frequent?

Authors:  Sai Mun Leong; Karen M L Tan; Hui Wen Chua; Doreen Tan; Delly Fareda; Saabry Osmany; Mo-Huang Li; Steven Tucker; Evelyn S C Koay
Journal:  J Hematol Oncol       Date:  2015-06-25       Impact factor: 17.388

8.  Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.

Authors:  Peng Gao; Xuan-Zhang Huang; Yong-Xi Song; Jing-Xu Sun; Xiao-Wan Chen; Yu Sun; Yu-Meng Jiang; Zhen-Ning Wang
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

Review 9.  Adjuvant chemotherapy.

Authors:  B Glimelius
Journal:  EJC Suppl       Date:  2013-09

10.  Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer.

Authors:  Ajay A Patel; Sairaman Nagarajan; Eli D Scher; Caitlin Ab Schonewolf; Sairam Balasubramanian; Elizabeth Poplin; Rebecca Moss; David August; Darren Carpizo; Laleh Melstrom; Salma K Jabbour
Journal:  Pancreat Disord Ther       Date:  2015-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.